Feline Cholangiohepatitis: Causes, Symptoms, Diagnosis, and Evidence‑Based Treatment

Feline cholangiohepatitis (CCHS) is the most common acquired liver disease in cats. Understanding its causes, clinical presentation, diagnostic approach, and management options is essential for any cat owner or veterinarian aiming to provide optimal care.

Quick Overview

• Other Names: CCHS
• Common Symptoms: Lethargy, poor appetite, vomiting, jaundice, fever, weight loss
• Long‑term Management: Many cases require ongoing therapy
• Vaccine: None available
• Treatment Options: Acute CCHS usually needs antibiotics; chronic forms target underlying inflammation and associated diseases such as pancreatitis and IBD
• Home Care: Complete prescribed antibiotic courses and adhere to follow‑up visits. Treatment can be prolonged; never stop or adjust medication without veterinary guidance.

What Is CCHS?

CCHS refers to inflammation of the bile ducts, gallbladder, and sometimes the liver itself. The term cholangitis derives from “chol” (bile) and “angio” (vessel), while cholangiohepatitis adds the hepatic component. Bile is essential for fat digestion and toxin excretion; disruption of its flow leads to the clinical signs seen in CCHS.

Underlying Causes

Two primary forms exist, each with distinct etiologies:

1. Suppurative (Neutrophilic) Cholangitis

Characterized by acute bacterial infection, often involving intestinal flora that enter the bile ducts through the common duct. Gallstones, foreign bodies, or anatomical anomalies can predispose cats to secondary infection.

2. Lymphoplasmacytic (Chronic) Cholangitis

Involves a slower, immune‑mediated process without overt bacterial infection. This form typically appears in middle‑aged to older cats and may be associated with dietary protein sensitivities.

Additional subtypes include:

• Feline lymphocytic portal hepatitis (liver‑only involvement)
• Destructive (sclerosing) cholangitis (scarring of bile ducts)
• Cholangitis from liver flukes (tropical regions)

Common Contributing Conditions

Comorbidities frequently coexist with CCHS, particularly pancreatitis and inflammatory bowel disease (IBD). A 2022 study reported that 88% of cats with suppurative CCHS had IBD and 93% had pancreatitis. When all three organs are inflamed simultaneously, the term triaditis is used.

• Cholelithiasis (gallstones)
• Extrahepatic bile duct obstruction
• Toxoplasmosis
• Primary cholangitis
• Pancreatitis
• Neoplasia of the pancreas, gallbladder, or bile ducts
• Biliary cystadenoma
• Bile duct malformations

Clinical Signs

Signs vary with the form of CCHS:

Acute Suppurative CCHS

• Reduced appetite
• Lethargy
• Vomiting
• Jaundice (30–60% of cases)
• Weight loss
• Fever (20–40% of cases)

Chronic Lymphoplasmacytic CCHS

• Intermittent vomiting and diarrhea
• Gradual weight loss
• Fluctuating appetite
• Transient jaundice

Prompt veterinary evaluation is advised if a cat exhibits sudden lethargy, loss of appetite, or vomiting for more than 2–3 days.

Potential Complications

Key complications include hepatic lipidosis, particularly when a cat becomes anorexic. CCHS is the most common cause of hepatic lipidosis after digestive tract lymphoma and IBD. Severe cases may require hospitalization, intensive fluid therapy, and nutritional support.

Diagnostic Approach

Diagnosis begins with a thorough physical exam. While signs like jaundice or fever are helpful, they are not present in all cases. Laboratory and imaging studies are essential.

Bloodwork

• Complete Blood Count: Neutrophil elevation in ~30% of suppurative cases.
• Serum Chemistry: AST elevation in 98% of cats; ALT in ~50%; ALP in <50%.
• Bilirubin: Direct bilirubin elevated in ~67% of cases.
• Pancreatic Enzymes: Feline pancreatic lipase (fPL) helps identify concurrent pancreatitis.
• Bile Acids: Useful when liver function is suspected but other tests are inconclusive.
• Coagulation Times: PT and PTT assess liver‑produced clotting factors.

Imaging

• X‑Rays: May show liver enlargement in ~20% of cases; generally non‑specific.
• Abdominal Ultrasound: Gold standard for visualizing gallbladder, bile ducts, liver parenchyma, pancreas, and lymph nodes. Typical findings include gallbladder distension, bile sludge, gallstones, ductal dilation, and abnormal liver texture.
• Guided Aspiration: Ultrasound‑guided sampling of gallbladder fluid for culture and cytology; liver or pancreatic biopsies if indicated.

Additional Tests

• Clotting Times (PT/PTT)
• Histopathology via biopsy (ultrasound‑guided or surgical)
• Advanced imaging (CT/MRI) for complex cases

Treatment Strategies

Acute Suppurative CCHS

• Antibiotics: Culture‑guided when possible; otherwise empiric therapy lasting 4–6 weeks.
• Ursodeoxycholic acid (ursodiol) and S‑adenosyl‑L‑methionine (SAMe, e.g., Denamarin) to protect bile flow and hepatocytes.
• Anti‑emetics: Cerenia (maropitant), famotidine, omeprazole, ondansetron.
• Analgesics for pain from gallstones or pancreatitis.
• Appetite stimulants: capromorelin (Elura), mirtazapine (Mirataz), cyproheptadine.
• Hospitalization for severe cases, providing IV fluids, nutrition, and close monitoring.
• Diet: Highly digestible diet with moderate protein/fat; hypoallergenic diet if IBD is present.

Chronic Lymphoplasmacytic CCHS

• Immunosuppressive steroids (e.g., prednisolone) to control inflammation.
• Hypoallergenic or novel protein diet to reduce antigenic stimulation.
• Long‑term liver protectants (ursodiol, Denamarin).
• Regular appetite stimulants and anti‑emetics as needed.
• Periodic rechecks: physical exam, bloodwork, and imaging to monitor disease activity.

Both forms require coordinated management of associated conditions such as pancreatitis and IBD to improve prognosis.

Home Care and Monitoring

• Adhere strictly to antibiotic courses and scheduled follow‑ups.
• Monitor weight every 2–3 months, especially in cats over 10 years old.
• Watch for vomiting frequency >2 times per month, which may indicate underlying GI disease.
• Seek veterinary attention promptly if the cat stops eating or shows worsening lethargy.
• Maintain a stable, balanced diet and ensure fresh water availability.

Prevention and Early Detection

There is no definitive preventive measure for CCHS, as the disease can arise without clear risk factors. Early detection hinges on routine examinations and vigilance for subtle changes in appetite, weight, or behavior. Annual or biannual blood panels (AST, ALT, bilirubin) can serve as useful screening tools, especially in middle‑aged to senior cats.

References

1. Weir, M., & Ward, E. (n.d.). Cholangitis/Cholangiohepatitis Syndrome in Cats. VCA Animal Hospitals.
2. Brooks, W. (2023b, November 1). Cholangitis (Cholangiohepatitis) in Cats. Veterinary Partner.
3. Center, S. (2023, August). Feline Cholangitis/Cholangiohepatitis Syndrome. Merck Veterinary Manual (Professional Version).
4. Cornell University College of Veterinary Medicine. (n.d.-a). Cholangiohepatitis. Cornell Feline Health Center.
5. Randolph, J. F., Warner, K. L., Flanders, J. A., & Harvey, H. J. (2021). Clinical features, concurrent disorders, and survival time in cats with suppurative cholangitis-cholangiohepatitis syndrome. Journal of the American Veterinary Medical Association, 260(2), 212–227. https://doi.org/10.2460/javma.20.10.0555
6. Jaffey, J. A. (2022). Feline cholangitis/cholangiohepatitis complex. Journal of Small Animal Practice, 63(8), 573–589. https://doi.org/10.1111/jsap.13508
7. Forman, M. (2020, February 17). Neutrophilic Cholangitis in Cats: Are You Missing Out on an Easy Diagnosis? Today’s Veterinary Practice.
8. Center, S. (2024, September). Disorders of the Liver and Gallbladder in Cats. Merck Veterinary Manual (Pet Owner Version).
9. Ishida, T. (2011). Feline Triaditis: Inflammatory Diseases of the Liver, Pancreas and Small Intestine. Veterinary Information Network.
10. Webb, C. B. (2018). Hepatic lipidosis: Clinical review drawn from collective effort. Journal of Feline Medicine and Surgery, 20(3), 217–227. https://doi.org/10.1177/1098612x18758591